U.S. Markets close in 27 mins

Gilead Pens $5 Billion Research Deal — Why Analysts Still Want A Merger

ALLISON GATLIN
Gilead Pens $5 Billion Research Deal — Why Analysts Still Want A Merger

Galapagos stock rocketed to an all-time high Monday on a deeper $5.05 billion research and development deal with giant biotech company Gilead Sciences. Gilead stock also gained on the news.